Actively Recruiting

Age: 18Years +
All Genders
ID07521436

Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention: A Comparison Between Women and Men

Led by Istituti Clinici Scientifici Maugeri SpA · Updated on 2026-04-29

200

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are examining how well people with cardiovascular disease understand their risk factors and perceive their chances of having more heart-related problems. This study focuses on individuals who have already experienced cardiovascular events, comparing awareness and risk perception between women and men in secondary prevention. It highlights that women may have less knowledge and lower perception of their risks, which might affect their treatment adherence and follow-up participation. This observational study does not involve any treatment or intervention. Instead, participants complete surveys that assess their awareness of general and sex-specific cardiovascular risk factors, such as early menopause and autoimmune disorders. The study compares responses from men and women to understand differences in knowledge and risk perception after a cardiovascular event. Participants will complete questionnaires at enrollment to report their understanding of cardiovascular risk factors and their personal risk perceptions. Researchers will analyze the differences between sexes and between primary and secondary prevention groups. The study monitors self-reported data without any treatment, focusing on cognitive and emotional responses related to cardiovascular risk over the study period.

CONDITIONS

Brief Title

Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention Among Women and Men

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female participants aged 18 years at the time of signing informed consent
  • Individuals with atherosclerotic cardiovascular disease (ASCVD), including ischemic heart disease, cerebrovascular disease (excluding transient ischemic attack and hemorrhages), peripheral arterial disease, or atherosclerotic aortic disease
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Inability or difficulty in completing the questionnaires in Italian or functional illiteracy
  • History of or current severe psychiatric disorder that could compromise questionnaire reliability
  • Refusal or withdrawal of informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surveillance

Duration - At enrollment

Participants who have a history of cardiovascular disease are observed to assess their awareness and perception of cardiovascular risk factors.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Istituti Clinici Scientifici IRCCS Maugeri

Milan, Italy

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Feasibility and Acceptability of a Novel Algorithm for Physi...

Hypertension

Actively Recruiting

3 locations

A Phase III, Randomised, Double-blind, Placebo-controlled St...

Cardiovascular Disease

Actively Recruiting

1333 locations

The Role of Androgen Deprivation Therapy in Cardiovascular D...

Prostate Cancer

Actively Recruiting

54 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here